Clinical trial
Clinical Study to Assess the Safety and Performance of the Xeltis Hemodialysis Access Graft
NCT06494631 is registered in ClinicalTrials.gov with Xeltis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Assess the Safety and Performance of the Xeltis Hemodialysis Access Graft
- Lead sponsor
- Xeltis
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- November 11, 2024
- Completion date
- January 31, 2032
- Enrollment
- 140 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease